Monitoring Troponin I and CRP During Clozapine Titration: Assessing Adherence to Myocarditis Protocols
BJPsych Open · 2026-06 · 12 (S1) · S175-S175
DOI: 10.1192/bjo.2026.11429 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 30.06.2026. Verfasst von Tasfique Chowdhury und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Clozapine remains the only licensed treatment for patients with treatment-resistant schizophrenia and is highly effective, but its use is limited by potentially serious adverse effects such as clozapine-associated myocarditis, as has been highlighted by the recent position statement by the RCPsych. The risk of myocarditis is greatest within the first 6–8 weeks of treatment, during which early detection relies on monitoring inflammatory markers and cardiac biomarkers, particularly CRP and troponin. Evidence-based monitoring for myocarditis is guided by the Ronaldson et al. algorithm, which is adopted by the Maudsley Prescribing Guidelines and supported by ZTAS, recommending weekly troponin and CRP monitoring during the first four weeks of titration. However, under local protocols normal reference ranges are often based on acute cardiac pathways, meaning that mildly raised troponin levels often prompt additional testing, leading to unnecessary investigations and resource use. This audit evaluated adherence to guideline-recommended monitoring of troponin and CRP during clozapine initiation or re-titration on inpatient general adult psychiatry wards. It also assessed the management of abnormal results and examined whether troponin testing was over-utilised when not clinically indicated.
Methods
A retrospective audit was conducted at Swallownest Court (RDaSH NHS Foundation Trust), reviewing all patients who commenced or retitrated clozapine between 1 July and 30 November 2025. Data were extracted from electronic records, including baseline investigations, weekly troponin and CRP results, and clinical responses to abnormal findings. Practice was compared against Maudsley and Ronaldson monitoring standards.
Results
Ten patients were included. Baseline troponin and CRP were documented in 80% and baseline ECG in 90%. Five patients (50%) developed mildly elevated troponin levels (>3 ng/L, but
Zitieren
APA
Chowdhury, T., & Martin, A. (2026). Monitoring Troponin I and CRP During Clozapine Titration: Assessing Adherence to Myocarditis Protocols. BJPsych Open, 12(S1), S175-S175. https://doi.org/10.1192/bjo.2026.11429
Vancouver
Chowdhury T, Martin A. Monitoring Troponin I and CRP During Clozapine Titration: Assessing Adherence to Myocarditis Protocols. BJPsych Open. 2026;12(S1):S175-S175. doi:10.1192/bjo.2026.11429
BibTeX
@article{Chowdhury2026,
author = {Chowdhury, Tasfique and Martin, Alistair},
title = {Monitoring Troponin I and CRP During Clozapine Titration: Assessing Adherence to Myocarditis Protocols},
journal = {BJPsych Open},
year = {2026},
volume = {12},
number = {S1},
pages = {S175--S175},
doi = {10.1192/bjo.2026.11429}
}
EUVIMED